295 results
Page 5 of 15
424B5
duruhm
26 Mar 14
Prospectus supplement for primary offering
12:00am
DEFA14A
7b58yq i1g3mtvlh
7 Oct 13
Additional proxy soliciting materials
12:00am
8-K
4i1v8cyhat
4 Oct 13
BioTime Announces Additional Products in Development Based on HyStem® Technology
12:00am
8-K
wa3mkvn
21 Aug 13
BioTime Announces the Appointment of Lesley Stolz as Executive Vice President of Corporate Development
12:00am
8-K
EX-99.1
38c7v1 i4
21 Aug 13
BioTime Announces the Appointment of Lesley Stolz as Executive Vice President of Corporate Development
12:00am
8-K
EX-99.1
yu5fke8
5 Aug 13
BioTime’s Subsidiary OncoCyte Corporation Publishes Data on the Gene FSIP1 as a Breast Cancer-Specific Marker
12:00am
424B3
cicb451um t5
2 Aug 13
Prospectus supplement
12:00am
8-K
EX-99.1
3s21pwlz7
16 Jul 13
BioTime CEO Dr. Michael West to Present at the Case Western Reserve University 6th Annual Regenerative Medicine Business Education Course
12:00am
8-K
EX-99.1
5jr9 ify8z
12 Jun 13
BioTime Appoints Henry L. Nordhoff to Board of Directors
12:00am
8-K
EX-99.1
xoz0p6a0063etv0
7 Jun 13
BioTime, Inc. Closes on $9 Million Financing
12:00am
424B5
wszsxcxa3gcw 4pb307h
3 Jun 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
t1fcxrkg0qcacr
3 Jun 13
BioTime, Inc. to Raise $9 Million in Registered Direct Offering
12:00am
8-K
EX-99.1
tei d9qwdnxgi
23 May 13
BioTime Announces Results of Vote at Special Meeting of Shareholders
12:00am